Drug Abuse Testing Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-01-19

Pages: 137 Pages

Report ld: 5744744

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Drug Abuse Testing Products was estimated to be worth US$ 10420 million in 2025 and is projected to reach US$ 18020 million, growing at a CAGR of 8.3% from 2026 to 2032.

Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.

Drug Abuse Testing Products Market Size(US$)

M= millions and B=billions

The surge in number of people who consume alcohol and illicit drugs such as marijuana, cocaine, and others, is one of the major drivers for the drug abuse testing market. In addition, technological advancements in drug screening/testing devices and stringent government regulations mandating drug screening boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global drug abuse testing market. Emerging markets such as the Asia-Pacific and LAMEA, provide lucrative opportunities for the drug abuse testing market growth.

This report provides a comprehensive view of the global market for Drug Abuse Testing Products, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Drug Abuse Testing Products market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Drug Abuse Testing Products.

Market Segmentation

Report Metric
Details
Report Title
Drug Abuse Testing Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 18020 million
CAGR(2026-2032)
8.3%
Market Size Available for Years
2026-2032
Global Drug Abuse Testing Products Companies Covered
Biomedical Diagnostics
BioMerieux
Abbott Laboratories
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Beckman Coulter
Siemens
F. Hoffmann-La Roche Ltd. (Genentech Inc.)
Laboratory Corporation Of America Holdings
Danaher Corporation
Express Diagnostics International Inc
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc
Drgerwerk Ag & Co.
Kgaa
Global Drug Abuse Testing Products Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Abuse Testing Products Market, Segment by Type
Analyzers
Rapid Testing Devices
Consumables
Global Drug Abuse Testing Products Market, Segment by Application
Workplaces and Schools
Criminal Justice Systems and Law Enforcement Agencies
Hospitals
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Drug Abuse Testing Products companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Drug Abuse Testing Products revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Drug Abuse Testing Products revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Drug Abuse Testing Products Product Introduction
    1.2 Global Drug Abuse Testing Products Market Size Forecast (2021–2032)
    1.3 Drug Abuse Testing Products Market Trends & Drivers
        1.3.1 Drug Abuse Testing Products Industry Trends
        1.3.2 Drug Abuse Testing Products Market Drivers & Opportunities
        1.3.3 Drug Abuse Testing Products Market Challenges
        1.3.4 Drug Abuse Testing Products Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Drug Abuse Testing Products Players Revenue Ranking (2025)
    2.2 Global Drug Abuse Testing Products Revenue by Company (2021–2026)
    2.3 Key Companies’ R&D and Operations Footprint and Headquarters
    2.4 Key Companies Drug Abuse Testing Products Product Offerings
    2.5 Key Companies General Availability (GA) Timeline for Drug Abuse Testing Products
    2.6 Drug Abuse Testing Products Market Competitive Analysis
        2.6.1 Drug Abuse Testing Products Market Concentration Rate (2021–2026)
        2.6.2 Top 5 and Top 10 Global Companies by Drug Abuse Testing Products Revenue in 2025
        2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Abuse Testing Products revenue, 2025
    2.7 Mergers & Acquisitions and Expansion

3 Segmentation Drug Abuse Testing Products Market Classification
    3.1 Introduction by Type
        3.1.1 Analyzers
        3.1.2 Rapid Testing Devices
        3.1.3 Consumables
        3.1.4 Global Drug Abuse Testing Products Sales Value by Type
            3.1.4.1 Global Drug Abuse Testing Products Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.4.2 Global Drug Abuse Testing Products Sales Value, by Type (2021–2032)
            3.1.4.3 Global Drug Abuse Testing Products Sales Value, by Type (%), 2021–2032

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Workplaces and Schools
        4.1.2 Criminal Justice Systems and Law Enforcement Agencies
        4.1.3 Hospitals
        4.1.4 Others
    4.2 Global Drug Abuse Testing Products Sales Value by Application
        4.2.1 Global Drug Abuse Testing Products Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Drug Abuse Testing Products Sales Value by Application (2021–2032)
        4.2.3 Global Drug Abuse Testing Products Sales Value by Application (%), 2021–2032

5 Segmentation by Region
    5.1 Global Drug Abuse Testing Products Sales Value by Region
        5.1.1 Global Drug Abuse Testing Products Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Drug Abuse Testing Products Sales Value by Region (2021–2026)
        5.1.3 Global Drug Abuse Testing Products Sales Value by Region (2027–2032)
        5.1.4 Global Drug Abuse Testing Products Sales Value by Region (%), 2021–2032
    5.2 North America
        5.2.1 North America Drug Abuse Testing Products Sales Value, 2021–2032
        5.2.2 North America Drug Abuse Testing Products Sales Value by Country (%), 2025 vs 2032
    5.3 Europe
        5.3.1 Europe Drug Abuse Testing Products Sales Value, 2021–2032
        5.3.2 Europe Drug Abuse Testing Products Sales Value by Country (%), 2025 vs 2032
    5.4 Asia Pacific
        5.4.1 Asia Pacific Drug Abuse Testing Products Sales Value, 2021–2032
        5.4.2 Asia Pacific Drug Abuse Testing Products Sales Value by Subregion (%), 2025 vs 2032
    5.5 South America
        5.5.1 South America Drug Abuse Testing Products Sales Value, 2021–2032
        5.5.2 South America Drug Abuse Testing Products Sales Value by Country (%), 2025 vs 2032
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Drug Abuse Testing Products Sales Value, 2021–2032
        5.6.2 Middle East & Africa Drug Abuse Testing Products Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Drug Abuse Testing Products Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Drug Abuse Testing Products Sales Value, 2021–2032
    6.3 United States
        6.3.1 United States Drug Abuse Testing Products Sales Value, 2021–2032
        6.3.2 United States Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Drug Abuse Testing Products Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Drug Abuse Testing Products Sales Value, 2021–2032
        6.4.2 Europe Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Drug Abuse Testing Products Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Drug Abuse Testing Products Sales Value, 2021–2032
        6.5.2 China Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Drug Abuse Testing Products Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Drug Abuse Testing Products Sales Value, 2021–2032
        6.6.2 Japan Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Drug Abuse Testing Products Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Drug Abuse Testing Products Sales Value, 2021–2032
        6.7.2 South Korea Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Drug Abuse Testing Products Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Drug Abuse Testing Products Sales Value, 2021–2032
        6.8.2 Southeast Asia Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Drug Abuse Testing Products Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Drug Abuse Testing Products Sales Value, 2021–2032
        6.9.2 India Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Drug Abuse Testing Products Sales Value by Application, 2025 vs 2032

7 Company Profiles
    7.1 Biomedical Diagnostics
        7.1.1 Biomedical Diagnostics Profile
        7.1.2 Biomedical Diagnostics Main Business
        7.1.3 Biomedical Diagnostics Drug Abuse Testing Products Products, Services, and Solutions
        7.1.4 Biomedical Diagnostics Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.1.5 Biomedical Diagnostics Recent Developments
    7.2 BioMerieux
        7.2.1 BioMerieux Profile
        7.2.2 BioMerieux Main Business
        7.2.3 BioMerieux Drug Abuse Testing Products Products, Services, and Solutions
        7.2.4 BioMerieux Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.2.5 BioMerieux Recent Developments
    7.3 Abbott Laboratories
        7.3.1 Abbott Laboratories Profile
        7.3.2 Abbott Laboratories Main Business
        7.3.3 Abbott Laboratories Drug Abuse Testing Products Products, Services, and Solutions
        7.3.4 Abbott Laboratories Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.3.5 Abbott Laboratories Recent Developments
    7.4 Bio-Rad
        7.4.1 Bio-Rad Profile
        7.4.2 Bio-Rad Main Business
        7.4.3 Bio-Rad Drug Abuse Testing Products Products, Services, and Solutions
        7.4.4 Bio-Rad Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.4.5 Bio-Rad Recent Developments
    7.5 Dako
        7.5.1 Dako Profile
        7.5.2 Dako Main Business
        7.5.3 Dako Drug Abuse Testing Products Products, Services, and Solutions
        7.5.4 Dako Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.5.5 Dako Recent Developments
    7.6 DiaSorin
        7.6.1 DiaSorin Profile
        7.6.2 DiaSorin Main Business
        7.6.3 DiaSorin Drug Abuse Testing Products Products, Services, and Solutions
        7.6.4 DiaSorin Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.6.5 DiaSorin Recent Developments
    7.7 Eiken
        7.7.1 Eiken Profile
        7.7.2 Eiken Main Business
        7.7.3 Eiken Drug Abuse Testing Products Products, Services, and Solutions
        7.7.4 Eiken Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.7.5 Eiken Recent Developments
    7.8 Fujirebio
        7.8.1 Fujirebio Profile
        7.8.2 Fujirebio Main Business
        7.8.3 Fujirebio Drug Abuse Testing Products Products, Services, and Solutions
        7.8.4 Fujirebio Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.8.5 Fujirebio Recent Developments
    7.9 Beckman Coulter
        7.9.1 Beckman Coulter Profile
        7.9.2 Beckman Coulter Main Business
        7.9.3 Beckman Coulter Drug Abuse Testing Products Products, Services, and Solutions
        7.9.4 Beckman Coulter Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.9.5 Beckman Coulter Recent Developments
    7.10 Siemens
        7.10.1 Siemens Profile
        7.10.2 Siemens Main Business
        7.10.3 Siemens Drug Abuse Testing Products Products, Services, and Solutions
        7.10.4 Siemens Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.10.5 Siemens Recent Developments
    7.11 F. Hoffmann-La Roche Ltd. (Genentech Inc.)
        7.11.1 F. Hoffmann-La Roche Ltd. (Genentech Inc.) Profile
        7.11.2 F. Hoffmann-La Roche Ltd. (Genentech Inc.) Main Business
        7.11.3 F. Hoffmann-La Roche Ltd. (Genentech Inc.) Drug Abuse Testing Products Products, Services, and Solutions
        7.11.4 F. Hoffmann-La Roche Ltd. (Genentech Inc.) Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.11.5 F. Hoffmann-La Roche Ltd. (Genentech Inc.) Recent Developments
    7.12 Laboratory Corporation Of America Holdings
        7.12.1 Laboratory Corporation Of America Holdings Profile
        7.12.2 Laboratory Corporation Of America Holdings Main Business
        7.12.3 Laboratory Corporation Of America Holdings Drug Abuse Testing Products Products, Services, and Solutions
        7.12.4 Laboratory Corporation Of America Holdings Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.12.5 Laboratory Corporation Of America Holdings Recent Developments
    7.13 Danaher Corporation
        7.13.1 Danaher Corporation Profile
        7.13.2 Danaher Corporation Main Business
        7.13.3 Danaher Corporation Drug Abuse Testing Products Products, Services, and Solutions
        7.13.4 Danaher Corporation Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.13.5 Danaher Corporation Recent Developments
    7.14 Express Diagnostics International Inc
        7.14.1 Express Diagnostics International Inc Profile
        7.14.2 Express Diagnostics International Inc Main Business
        7.14.3 Express Diagnostics International Inc Drug Abuse Testing Products Products, Services, and Solutions
        7.14.4 Express Diagnostics International Inc Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.14.5 Express Diagnostics International Inc Recent Developments
    7.15 Quest Diagnostics Incorporated
        7.15.1 Quest Diagnostics Incorporated Profile
        7.15.2 Quest Diagnostics Incorporated Main Business
        7.15.3 Quest Diagnostics Incorporated Drug Abuse Testing Products Products, Services, and Solutions
        7.15.4 Quest Diagnostics Incorporated Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.15.5 Quest Diagnostics Incorporated Recent Developments
    7.16 Thermo Fisher Scientific Inc
        7.16.1 Thermo Fisher Scientific Inc Profile
        7.16.2 Thermo Fisher Scientific Inc Main Business
        7.16.3 Thermo Fisher Scientific Inc Drug Abuse Testing Products Products, Services, and Solutions
        7.16.4 Thermo Fisher Scientific Inc Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.16.5 Thermo Fisher Scientific Inc Recent Developments
    7.17 Drgerwerk Ag & Co.
        7.17.1 Drgerwerk Ag & Co. Profile
        7.17.2 Drgerwerk Ag & Co. Main Business
        7.17.3 Drgerwerk Ag & Co. Drug Abuse Testing Products Products, Services, and Solutions
        7.17.4 Drgerwerk Ag & Co. Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.17.5 Drgerwerk Ag & Co. Recent Developments
    7.18 Kgaa
        7.18.1 Kgaa Profile
        7.18.2 Kgaa Main Business
        7.18.3 Kgaa Drug Abuse Testing Products Products, Services, and Solutions
        7.18.4 Kgaa Drug Abuse Testing Products Revenue (US$ Million), 2021–2026
        7.18.5 Kgaa Recent Developments

8 Industry Chain Analysis
    8.1 Drug Abuse Testing Products Value Chain
    8.2 Drug Abuse Testing Products Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream (Customer) Analysis
    8.5 Sales Model and Sales Channelss
        8.5.1 Drug Abuse Testing Products Sales Model
        8.5.2 Sales Channels
        8.5.3 Drug Abuse Testing Products Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Drug Abuse Testing Products Market Trends
 Table 2. Drug Abuse Testing Products Market Drivers & Opportunities
 Table 3. Drug Abuse Testing Products Market Challenges
 Table 4. Drug Abuse Testing Products Market Restraints
 Table 5. Global Drug Abuse Testing Products Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Drug Abuse Testing Products Revenue Market Share by Company (2021–2026)
 Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
 Table 8. Key Companies Drug Abuse Testing Products Product Type
 Table 9. Key Companies General Availability (GA) Timeline for Drug Abuse Testing Products
 Table 10. Global Drug Abuse Testing Products Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Abuse Testing Products revenue, 2025
 Table 12. Mergers & Acquisitions and Expansion Plans
 Table 13. Global Drug Abuse Testing Products Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 14. Global Drug Abuse Testing Products Sales Value by Type (US$ Million), 2021–2026
 Table 15. Global Drug Abuse Testing Products Sales Value by Type (US$ Million), 2027–2032
 Table 16. Global Drug Abuse Testing Products Sales Market Share in Value by Type (2021–2026)
 Table 17. Global Drug Abuse Testing Products Sales Market Share in Value by Type (2027–2032)
 Table 18. Global Drug Abuse Testing Products Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 19. Global Drug Abuse Testing Products Sales Value by Application (US$ Million), 2021–2026
 Table 20. Global Drug Abuse Testing Products Sales Value by Application (US$ Million), 2027–2032
 Table 21. Global Drug Abuse Testing Products Sales Market Share in Value by Application (2021–2026)
 Table 22. Global Drug Abuse Testing Products Sales Market Share in Value by Application (2027–2032)
 Table 23. Global Drug Abuse Testing Products Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 24. Global Drug Abuse Testing Products Sales Value by Region (US$ Million), 2021–2026
 Table 25. Global Drug Abuse Testing Products Sales Value by Region (US$ Million), 2027–2032
 Table 26. Global Drug Abuse Testing Products Sales Value by Region (%), 2021–2026
 Table 27. Global Drug Abuse Testing Products Sales Value by Region (%), 2027–2032
 Table 28. Key Countries/Regions Drug Abuse Testing Products Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 29. Key Countries/Regions Drug Abuse Testing Products Sales Value, (US$ Million), 2021–2026
 Table 30. Key Countries/Regions Drug Abuse Testing Products Sales Value, (US$ Million), 2027–2032
 Table 31. Biomedical Diagnostics Basic Information List
 Table 32. Biomedical Diagnostics Description and Business Overview
 Table 33. Biomedical Diagnostics Drug Abuse Testing Products Products, Services, and Solutions
 Table 34. Revenue (US$ Million) in Drug Abuse Testing Products Business of Biomedical Diagnostics (2021–2026)
 Table 35. Biomedical Diagnostics Recent Developments
 Table 36. BioMerieux Basic Information List
 Table 37. BioMerieux Description and Business Overview
 Table 38. BioMerieux Drug Abuse Testing Products Products, Services, and Solutions
 Table 39. Revenue (US$ Million) in Drug Abuse Testing Products Business of BioMerieux (2021–2026)
 Table 40. BioMerieux Recent Developments
 Table 41. Abbott Laboratories Basic Information List
 Table 42. Abbott Laboratories Description and Business Overview
 Table 43. Abbott Laboratories Drug Abuse Testing Products Products, Services, and Solutions
 Table 44. Revenue (US$ Million) in Drug Abuse Testing Products Business of Abbott Laboratories (2021–2026)
 Table 45. Abbott Laboratories Recent Developments
 Table 46. Bio-Rad Basic Information List
 Table 47. Bio-Rad Description and Business Overview
 Table 48. Bio-Rad Drug Abuse Testing Products Products, Services, and Solutions
 Table 49. Revenue (US$ Million) in Drug Abuse Testing Products Business of Bio-Rad (2021–2026)
 Table 50. Bio-Rad Recent Developments
 Table 51. Dako Basic Information List
 Table 52. Dako Description and Business Overview
 Table 53. Dako Drug Abuse Testing Products Products, Services, and Solutions
 Table 54. Revenue (US$ Million) in Drug Abuse Testing Products Business of Dako (2021–2026)
 Table 55. Dako Recent Developments
 Table 56. DiaSorin Basic Information List
 Table 57. DiaSorin Description and Business Overview
 Table 58. DiaSorin Drug Abuse Testing Products Products, Services, and Solutions
 Table 59. Revenue (US$ Million) in Drug Abuse Testing Products Business of DiaSorin (2021–2026)
 Table 60. DiaSorin Recent Developments
 Table 61. Eiken Basic Information List
 Table 62. Eiken Description and Business Overview
 Table 63. Eiken Drug Abuse Testing Products Products, Services, and Solutions
 Table 64. Revenue (US$ Million) in Drug Abuse Testing Products Business of Eiken (2021–2026)
 Table 65. Eiken Recent Developments
 Table 66. Fujirebio Basic Information List
 Table 67. Fujirebio Description and Business Overview
 Table 68. Fujirebio Drug Abuse Testing Products Products, Services, and Solutions
 Table 69. Revenue (US$ Million) in Drug Abuse Testing Products Business of Fujirebio (2021–2026)
 Table 70. Fujirebio Recent Developments
 Table 71. Beckman Coulter Basic Information List
 Table 72. Beckman Coulter Description and Business Overview
 Table 73. Beckman Coulter Drug Abuse Testing Products Products, Services, and Solutions
 Table 74. Revenue (US$ Million) in Drug Abuse Testing Products Business of Beckman Coulter (2021–2026)
 Table 75. Beckman Coulter Recent Developments
 Table 76. Siemens Basic Information List
 Table 77. Siemens Description and Business Overview
 Table 78. Siemens Drug Abuse Testing Products Products, Services, and Solutions
 Table 79. Revenue (US$ Million) in Drug Abuse Testing Products Business of Siemens (2021–2026)
 Table 80. Siemens Recent Developments
 Table 81. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Basic Information List
 Table 82. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Description and Business Overview
 Table 83. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Drug Abuse Testing Products Products, Services, and Solutions
 Table 84. Revenue (US$ Million) in Drug Abuse Testing Products Business of F. Hoffmann-La Roche Ltd. (Genentech Inc.) (2021–2026)
 Table 85. F. Hoffmann-La Roche Ltd. (Genentech Inc.) Recent Developments
 Table 86. Laboratory Corporation Of America Holdings Basic Information List
 Table 87. Laboratory Corporation Of America Holdings Description and Business Overview
 Table 88. Laboratory Corporation Of America Holdings Drug Abuse Testing Products Products, Services, and Solutions
 Table 89. Revenue (US$ Million) in Drug Abuse Testing Products Business of Laboratory Corporation Of America Holdings (2021–2026)
 Table 90. Laboratory Corporation Of America Holdings Recent Developments
 Table 91. Danaher Corporation Basic Information List
 Table 92. Danaher Corporation Description and Business Overview
 Table 93. Danaher Corporation Drug Abuse Testing Products Products, Services, and Solutions
 Table 94. Revenue (US$ Million) in Drug Abuse Testing Products Business of Danaher Corporation (2021–2026)
 Table 95. Danaher Corporation Recent Developments
 Table 96. Express Diagnostics International Inc Basic Information List
 Table 97. Express Diagnostics International Inc Description and Business Overview
 Table 98. Express Diagnostics International Inc Drug Abuse Testing Products Products, Services, and Solutions
 Table 99. Revenue (US$ Million) in Drug Abuse Testing Products Business of Express Diagnostics International Inc (2021–2026)
 Table 100. Express Diagnostics International Inc Recent Developments
 Table 101. Quest Diagnostics Incorporated Basic Information List
 Table 102. Quest Diagnostics Incorporated Description and Business Overview
 Table 103. Quest Diagnostics Incorporated Drug Abuse Testing Products Products, Services, and Solutions
 Table 104. Revenue (US$ Million) in Drug Abuse Testing Products Business of Quest Diagnostics Incorporated (2021–2026)
 Table 105. Quest Diagnostics Incorporated Recent Developments
 Table 106. Thermo Fisher Scientific Inc Basic Information List
 Table 107. Thermo Fisher Scientific Inc Description and Business Overview
 Table 108. Thermo Fisher Scientific Inc Drug Abuse Testing Products Products, Services, and Solutions
 Table 109. Revenue (US$ Million) in Drug Abuse Testing Products Business of Thermo Fisher Scientific Inc (2021–2026)
 Table 110. Thermo Fisher Scientific Inc Recent Developments
 Table 111. Drgerwerk Ag & Co. Basic Information List
 Table 112. Drgerwerk Ag & Co. Description and Business Overview
 Table 113. Drgerwerk Ag & Co. Drug Abuse Testing Products Products, Services, and Solutions
 Table 114. Revenue (US$ Million) in Drug Abuse Testing Products Business of Drgerwerk Ag & Co. (2021–2026)
 Table 115. Drgerwerk Ag & Co. Recent Developments
 Table 116. Kgaa Basic Information List
 Table 117. Kgaa Description and Business Overview
 Table 118. Kgaa Drug Abuse Testing Products Products, Services, and Solutions
 Table 119. Revenue (US$ Million) in Drug Abuse Testing Products Business of Kgaa (2021–2026)
 Table 120. Kgaa Recent Developments
 Table 121. Revenue (US$ Million) in Drug Abuse Testing Products Business of Company 40 (2021–2026)
 Table 122. Company 40 Recent Developments
 Table 123. Key Raw Materials Lists
 Table 124. Key Suppliers of Raw Materials Lists
 Table 125. Drug Abuse Testing Products Downstream Customers
 Table 126. Drug Abuse Testing Products Distributors List
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources


List of Figures
 Figure 1. Drug Abuse Testing Products Product Picture
 Figure 2. Global Drug Abuse Testing Products Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 4. Drug Abuse Testing Products Report Years Considered
 Figure 5. Global Drug Abuse Testing Products Players Revenue Ranking (US$ Million), 2025
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Drug Abuse Testing Products Revenue in 2025
 Figure 7. Drug Abuse Testing Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 8. Analyzers Picture
 Figure 9. Rapid Testing Devices Picture
 Figure 10. Consumables Picture
 Figure 11. Global Drug Abuse Testing Products Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Drug Abuse Testing Products Sales Value Market Share by Type, 2025 & 2032
 Figure 13. Product Picture of Workplaces and Schools
 Figure 14. Product Picture of Criminal Justice Systems and Law Enforcement Agencies
 Figure 15. Product Picture of Hospitals
 Figure 16. Product Picture of Others
 Figure 17. Global Drug Abuse Testing Products Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Drug Abuse Testing Products Sales Value Market Share by Application, 2025 & 2032
 Figure 19. North America Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 20. North America Drug Abuse Testing Products Sales Value by Country (%), 2025 vs 2032
 Figure 21. Europe Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 22. Europe Drug Abuse Testing Products Sales Value by Country (%), 2025 vs 2032
 Figure 23. Asia Pacific Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 24. Asia Pacific Drug Abuse Testing Products Sales Value by Subregion (%), 2025 vs 2032
 Figure 25. South America Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 26. South America Drug Abuse Testing Products Sales Value by Country (%), 2025 vs 2032
 Figure 27. Middle East & Africa Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 28. Middle East & Africa Drug Abuse Testing Products Sales Value by Country (%), 2025 vs 2032
 Figure 29. Key Countries/Regions Drug Abuse Testing Products Sales Value (%), 2021–2032
 Figure 30. United States Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 31. United States Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
 Figure 32. United States Drug Abuse Testing Products Sales Value by Application (%), 2025 vs 2032
 Figure 33. Europe Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 34. Europe Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
 Figure 35. Europe Drug Abuse Testing Products Sales Value by Application (%), 2025 vs 2032
 Figure 36. China Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 37. China Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
 Figure 38. China Drug Abuse Testing Products Sales Value by Application (%), 2025 vs 2032
 Figure 39. Japan Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 40. Japan Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
 Figure 41. Japan Drug Abuse Testing Products Sales Value by Application (%), 2025 vs 2032
 Figure 42. South Korea Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 43. South Korea Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
 Figure 44. South Korea Drug Abuse Testing Products Sales Value by Application (%), 2025 vs 2032
 Figure 45. Southeast Asia Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 46. Southeast Asia Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
 Figure 47. Southeast Asia Drug Abuse Testing Products Sales Value by Application (%), 2025 vs 2032
 Figure 48. India Drug Abuse Testing Products Sales Value (US$ Million), 2021–2032
 Figure 49. India Drug Abuse Testing Products Sales Value by Type (%), 2025 vs 2032
 Figure 50. India Drug Abuse Testing Products Sales Value by Application (%), 2025 vs 2032
 Figure 51. Drug Abuse Testing Products Value Chain
 Figure 52. Drug Abuse Testing Products Cost Structure
 Figure 53. Channels of Distribution (Direct Sales, and Distribution)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed

Description

The global market for Drug Abuse Testing Products was estimated to be worth US$ 10420 million in 2025 and is projected to reach US$ 18020 million, growing at a CAGR of 8.3% from 2026 to 2032.

Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.

The surge in number of people who consume alcohol and illicit drugs such as marijuana, cocaine, and others, is one of the major drivers for the drug abuse testing market. In addition, technological advancements in drug screening/testing devices and stringent government regulations mandating drug screening boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global drug abuse testing market. Emerging markets such as the Asia-Pacific and LAMEA, provide lucrative opportunities for the drug abuse testing market growth.

This report provides a comprehensive view of the global market for Drug Abuse Testing Products, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Drug Abuse Testing Products market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Drug Abuse Testing Products.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Drug Abuse Testing Products companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Drug Abuse Testing Products revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Drug Abuse Testing Products revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Global and United States Drug Abuse Testing Products Market Report & Forecast 2024-2030
Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.
Published: 2024-04-28
Pages: 130
USD 4350.00
(Single User License)
Drug Abuse Testing Products- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.
Published: 2024-04-28
Pages: 123
USD 3950.00
(Single User License)
Global Drug Abuse Testing Products Market Research Report 2024
Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.
Published: 2024-04-28
Pages: 93
USD 2900.00
(Single User License)
Global Drug Abuse Testing Products Market Research Report 2025
The global market for Drug Abuse Testing Products was valued at US$ 9702 million in the year 2024 and is projected to reach a revised size of US$ 16770 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published: 2025-03-10
Pages: 93
USD 2900.00
(Single User License)
Drug Abuse Testing Products- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Abuse Testing Products was estimated to be worth US$ 9702 million in 2024 and is forecast to a readjusted size of US$ 16770 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 132
USD 3950.00
(Single User License)
Global Drug Abuse Testing Products Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Abuse Testing Products market size was US$ 9702 million in 2024 and is forecast to a readjusted size of US$ 16770 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 107
USD 4250.00
(Single User License)
Global Drug Abuse Testing Products Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Abuse Testing Products market is projected to grow from US$ 9702 million in 2024 to US$ 16770 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 159
USD 4900.00
(Single User License)
Global Drug Abuse Testing Products Market Research Report 2026
The global Drug Abuse Testing Products market was valued at US$ 10420 million in 2025 and is anticipated to reach US$ 18020 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-15
Pages: 123
USD 2900.00
(Single User License)
Global Drug Abuse Testing Products Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Drug Abuse Testing Products market size was US$ 10420 million in 2025 and is forecast to reach a readjusted size of US$ 18020 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 106
USD 4250.00
(Single User License)
Global Drug Abuse Testing Products Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Drug Abuse Testing Products market is projected to grow from US$ 10420 million in 2025 to US$ 18020 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 149
USD 4900.00
(Single User License)

Global and United States Drug Abuse Testing Products Market Report & Forecast 2024-2030
Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.
Published: 2024-04-28
Pages: 130
USD 4350.00 ()
Drug Abuse Testing Products- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.
Published: 2024-04-28
Pages: 123
USD 3950.00 ()
Global Drug Abuse Testing Products Market Research Report 2024
Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.
Published: 2024-04-28
Pages: 93
USD 2900.00 ()
Global Drug Abuse Testing Products Market Research Report 2025
The global market for Drug Abuse Testing Products was valued at US$ 9702 million in the year 2024 and is projected to reach a revised size of US$ 16770 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published: 2025-03-10
Pages: 93
USD 2900.00 ()
Drug Abuse Testing Products- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Abuse Testing Products was estimated to be worth US$ 9702 million in 2024 and is forecast to a readjusted size of US$ 16770 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 132
USD 3950.00 ()
Global Drug Abuse Testing Products Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Abuse Testing Products market size was US$ 9702 million in 2024 and is forecast to a readjusted size of US$ 16770 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 107
USD 4250.00 ()
Global Drug Abuse Testing Products Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Abuse Testing Products market is projected to grow from US$ 9702 million in 2024 to US$ 16770 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 159
USD 4900.00 ()
Global Drug Abuse Testing Products Market Research Report 2026
The global Drug Abuse Testing Products market was valued at US$ 10420 million in 2025 and is anticipated to reach US$ 18020 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-15
Pages: 123
USD 2900.00 ()
Global Drug Abuse Testing Products Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Drug Abuse Testing Products market size was US$ 10420 million in 2025 and is forecast to reach a readjusted size of US$ 18020 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 106
USD 4250.00 ()
Global Drug Abuse Testing Products Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Drug Abuse Testing Products market is projected to grow from US$ 10420 million in 2025 to US$ 18020 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 149
USD 4900.00 ()